piperacillin and tazobactam

Generic: piperacillin sodium and tazobactam sodium

Labeler: eugia us llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name piperacillin and tazobactam
Generic Name piperacillin sodium and tazobactam sodium
Labeler eugia us llc
Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
INTRAVENOUS
Active Ingredients

piperacillin sodium 4 g/1, tazobactam sodium .5 g/1

Manufacturer
Eugia US LLC

Identifiers & Regulatory

Product NDC 55150-121
Product ID 55150-121_e9860d57-f7ab-4430-8a53-713d78c1dd30
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA065498
Listing Expiration 2026-12-31
Marketing Start 2012-01-23

Pharmacologic Class

Classes
penicillin-class antibacterial [epc] penicillins [cs] beta lactamase inhibitor [epc] beta lactamase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 55150121
Hyphenated Format 55150-121

Supplemental Identifiers

RxCUI
1659131 1659137 1659149
UPC
0355150119097 0355150120093 0355150121090
UNII
UXA545ABTT M98T69Q7HP

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name piperacillin and tazobactam (source: ndc)
Generic Name piperacillin sodium and tazobactam sodium (source: ndc)
Application Number ANDA065498 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 4 g/1
  • .5 g/1
source: ndc
Packaging
  • 10 VIAL in 1 BOX (55150-121-09) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL
source: ndc

Packages (1)

55150-121-09 10 VIAL in 1 BOX (55150-121-09) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL

Ingredients (2)

piperacillin sodium (4 g/1) tazobactam sodium (.5 g/1)

Linked Drug Pages (2)

Piperacillin and Tazobactam ndc-match (0.9) Piperacillin and Tazobactam ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "e9860d57-f7ab-4430-8a53-713d78c1dd30", "openfda": {"upc": ["0355150119097", "0355150120093", "0355150121090"], "unii": ["UXA545ABTT", "M98T69Q7HP"], "rxcui": ["1659131", "1659137", "1659149"], "spl_set_id": ["a5d8625e-e630-4076-bc55-46ebe861c6a5"], "manufacturer_name": ["Eugia US LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL in 1 BOX (55150-121-09)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL", "package_ndc": "55150-121-09", "marketing_start_date": "20120123"}], "brand_name": "Piperacillin and Tazobactam", "product_id": "55150-121_e9860d57-f7ab-4430-8a53-713d78c1dd30", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Penicillin-class Antibacterial [EPC]", "Penicillins [CS]", "beta Lactamase Inhibitor [EPC]", "beta Lactamase Inhibitors [MoA]"], "product_ndc": "55150-121", "generic_name": "Piperacillin Sodium and Tazobactam Sodium", "labeler_name": "Eugia US LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Piperacillin and Tazobactam", "active_ingredients": [{"name": "PIPERACILLIN SODIUM", "strength": "4 g/1"}, {"name": "TAZOBACTAM SODIUM", "strength": ".5 g/1"}], "application_number": "ANDA065498", "marketing_category": "ANDA", "marketing_start_date": "20120123", "listing_expiration_date": "20261231"}